NTHI (NTHI) reported R&D of $1.29M in Q1 2026.

How has NTHI's R&D changed year-over-year?

NTHI's R&D increased by 28.9% year-over-year, from $998.22K to $1.29M.

Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.

NTHI NTHI R&D

R&D at other companies

Bristol-Myers SquibbBMY

$2.65B+17.4%

Merck & Co.MRK

$12.59B+248%

Nuvectis Pharma, Inc.NVCT

$4.11M+11.6%

Oric Pharmaceuticals, Inc.ORIC

$31.44M+27.6%

Nuvation BioNUVB

$35.05M+42.5%

Crinetics PharmaceuticalsCRNX

$100.08M+31.3%

Other financials

Income statement

See full

Revenue$40.0K-7.0%

Operating income-$7.1M+77.9%

Net income-$8.8M+72.7%

EPS (diluted)-$0.38+78.7%

Balance sheet

See full

Cash & equivalents$138.6K-97.5%

Total debt$666.1K—

Total equity-$13.2M-37.5%

Total assets$3.3M-60.6%

Cash flow

See full

Operating cash flow-$7.0M-23.7%

CapEx$125.0K—

Free cash flow-$5.2M—

Valuation

See full

Market cap$114.62M+51.0%

Enterprise value$115.15M+51.1%

P/S1,432.9×—

Profitability

See full

Operating margin-46,870.7%—

Net margin-51,613.3%—

FCF margin-26,083.2%—

Returns & leverage

See full

Return on equity338.1%—

Debt / equity-0.1×—

Current ratio0.1×-0.3×

Where this comes from

Reported directly by NTHI in its filing.

Tagged under the XBRL concept us-gaap:ResearchAndDevelopmentExpense.

The official record: NTHI’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →

Ask your AI about NTHI's r&d.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is NTHI's R&D?: NTHI (NTHI) reported R&D of $1.29M in Q1 2026.
How has NTHI's R&D changed year-over-year?: NTHI's R&D increased by 28.9% year-over-year, from $998.22K to $1.29M.
What does R&D mean?: Costs of research activities to discover new knowledge and development activities to translate research into new or improved products, services, processes, or technologies.